EGFR Targeted Therapy in Advanced Hepatocellular Cancer

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
13:25

14th International Gastrointestinal Cancers Conference (IGICC2024)

Management of Fibrolamellar Liver Cancer

FEATURING Sunyoung Lee
  • 9 views
  • April 9, 2025
05:13

COR2ED The Heart of Medical Education

Advanced HCC Case Discussion: Treatment Options for Patients With Autoimmune Disorders

FEATURING Sammy Saab
  • 40 views
  • October 6, 2024
27:48

Lionel Kankeu Fonkoua

Current Approach to Frontline Systemic Therapy for Advanced Hepatocellular Carcinoma

  • 279 views
  • July 16, 2024
  • 2
07:47

Insights from 2024 ESMO GI Annual Meeting

ESMO GI 2024 Insights: Ten Years of Improvement in the Treatment of Liver Cancer

FEATURING Stephen L. Chan
  • 151 views
  • July 16, 2024
  • 1
13:44

Lorenza Rimassa

2L Systemic Therapy for Unresectable HCC

  • 287 views
  • July 5, 2024
04:27

COR2ED The Heart of Medical Education

Advanced HCC: When to Switch to 2L Treatment - Case Presentation

FEATURING Timon Vandamme
  • 107 views
  • April 19, 2024
  • 1
10:35

Integrity CE

The Role of Adjuvant Therapy Following HCC Resection

FEATURING Marina Baretti
  • 224 views
  • March 27, 2024
  • 2
11:34

Integrity CE

Intermediate Stage HCC With No Hx of Cirrhosis: Case Presentation and Panel Discussion - 2

FEATURING Marina Baretti, David Hsieh, Kelly Lafaro, Freddy Escorcia
  • 95 views
  • March 27, 2024
  • 1
22:02

ACG 2023 Conference Coverage

ACG 2023 Highlights: HCC Updates - Diagnosis and Management

FEATURING Robert Wong
  • 625 views
  • October 26, 2023
  • 6
05:27

Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Post Hoc Analysis of Patients With Nonviral Etiology From REFLECT Trial - Efficacy of Lenvatinib vs. Sorafenib in the 1L Treatment of Patients With Unresectable HCC"

FEATURING Ari Baron
  • 71 views
  • July 17, 2023
09:16

Ahmed O. Kaseb

Current Unmet Needs in Advanced HCC

  • 486 views
  • May 16, 2023
  • 4
46:36

Yale Cancer Center

Hepatocellular Carcinoma - From Screening to Treatment: Current Practice, Pearls, and Puzzles

FEATURING Tamar Taddei
  • 256 views
  • February 14, 2023
07:35

ASCO 2022 Conference Coverage

ASCO 2022 on an Open-Label, Multicenter, Randomized Phase II Study of Atezolizumab & Bevacizumab With Y90 TARE in Unresectable HCC

FEATURING Aiwu Ruth He, Filip Banovac
  • 241 views
  • June 23, 2022
40

ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on an Open-Label, Multicenter, Randomized Phase II Study of Atezolizumab & Bevacizumab With Y90 TARE in Unresectable HCC

FEATURING Aiwu Ruth He, Filip Banovac
  • 15 views
  • June 23, 2022
05:12

ASCO 2022 Conference Coverage

ASCO 2022 IMMUNIB Trial: A Single-Arm, Phase II Study Evaluating Safety & Efficacy of Nivo in Combination With Lenvatinib in Advanced Stage HCC

FEATURING Arndt Vogel
  • 343 views
  • June 15, 2022
  • 3
55:46

University of Colorado Cancer Center

UColorado Updates on Hepatocellular Carcinoma and Biliary Tract Cancers

FEATURING Lindsey Davis
  • 363 views
  • April 6, 2022
  • 3
15:29

10th Annual Winship Cancer Institute Gastrointestinal Cancer Virtual Symposium

Sequencing Therapy in Hepatocellular Carcinoma: A Good Problem to Have

FEATURING Mehmet Akce
  • 358 views
  • July 6, 2021
16:45

The Asian Oncology Society 1st Virtual International Conference

Systemic Treatment for Advanced HCC: Can Sorafenib Improve PFS/ORR vs. Lenvatinib in Unresectable Disease? Is There OS Benefit With Regorafenib After Sorafenib?

FEATURING Minsig Choi
  • 332 views
  • February 22, 2021
  • 3

EGFR Targeted Therapy in Advanced Hepatocellular Cancer

No subtopics